NasdaqGM - Delayed Quote USD

Connect Biopharma Holdings Limited (CNTB)

1.3500 -0.1500 (-10.00%)
At close: April 22 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
64,848.0000
64,848.0000
116,507.0000
96,560.0000
29,336.3231
Operating Income
-64,848.0000
-64,848.0000
-116,507.0000
-96,560.0000
-29,336.3231
Net Non Operating Interest Income Expense
2,691.0000
2,691.0000
1,523.0000
90.0000
-333.0629
Other Income Expense
2,774.0000
2,774.0000
-2,809.0000
-105,530.0000
-89,600.3551
Pretax Income
-59,383.0000
-59,383.0000
-117,793.0000
-202,000.0000
-119,269.7412
Tax Provision
120.0000
120.0000
298.0000
266.0000
--
Net Income Common Stockholders
-59,503.0000
-59,503.0000
-118,091.0000
-202,266.0000
-119,269.7412
Diluted NI Available to Com Stockholders
-59,503.0000
-59,503.0000
-118,091.0000
-202,266.0000
-119,269.7412
Basic EPS
-1.08
--
-2.15
-3.88
-2.21
Diluted EPS
-1.08
--
-2.15
-3.88
-2.21
Basic Average Shares
55,067.0000
--
55,044.0000
52,177.0000
53,941.6750
Diluted Average Shares
55,067.0000
--
55,044.0000
52,177.0000
53,941.6750
Total Operating Income as Reported
-62,074.0000
-62,074.0000
-119,316.0000
-98,107.0000
-30,270.0014
Total Expenses
64,848.0000
64,848.0000
116,507.0000
96,560.0000
29,336.3231
Net Income from Continuing & Discontinued Operation
-59,503.0000
-59,503.0000
-118,091.0000
-202,266.0000
-119,269.7412
Normalized Income
-61,659.2500
-61,659.2500
-115,871.7500
-123,942.7500
-29,669.3861
Interest Income
2,714.0000
2,714.0000
1,544.0000
97.0000
109.7455
Interest Expense
23.0000
23.0000
21.0000
7.0000
6.4286
Net Interest Income
2,691.0000
2,691.0000
1,523.0000
90.0000
-333.0629
EBIT
-59,360.0000
-59,360.0000
-117,772.0000
-201,993.0000
-119,263.3126
EBITDA
-58,372.0000
-58,372.0000
-116,741.0000
-201,359.0000
-119,042.4441
Reconciled Depreciation
988.0000
988.0000
1,031.0000
634.0000
220.8685
Net Income from Continuing Operation Net Minority Interest
-59,503.0000
-59,503.0000
-118,091.0000
-202,266.0000
-119,269.7412
Total Unusual Items Excluding Goodwill
2,875.0000
2,875.0000
-2,959.0000
-104,431.0000
-89,600.3551
Total Unusual Items
2,875.0000
2,875.0000
-2,959.0000
-104,431.0000
-89,600.3551
Normalized EBITDA
-61,247.0000
-61,247.0000
-113,782.0000
-96,928.0000
-29,442.0890
Tax Rate for Calcs
0.0003
0.0003
0.0003
0.0003
--
Tax Effect of Unusual Items
718.7500
718.7500
-739.7500
-26,107.7500
--
12/31/2020 - 3/19/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NRXP NRx Pharmaceuticals, Inc.
3.0000
-1.32%
 
TCON TRACON Pharmaceuticals, Inc.
1.8200
-7.14%
 
CDTX Cidara Therapeutics, Inc.
0.5139
-24.54%
 
GLMD Galmed Pharmaceuticals Ltd.
0.3641
-2.02%
 
EYEN Eyenovia, Inc.
0.5165
-9.48%
 
EQ Equillium, Inc.
1.6500
+2.48%
 
RLYB Rallybio Corporation
1.7700
+0.57%
 
LUMO Lumos Pharma, Inc.
2.6800
+3.47%
 
FNCH Finch Therapeutics Group, Inc.
2.3100
+6.45%
 
ATHE Alterity Therapeutics Limited
2.1300
+3.40%